Flu Remedies

FluGen is a clinical-stage biotechnology company focused on developing a universal influenza vaccine designed to provide broad, long-lasting protection against multiple strains of the virus. The company's lead candidate, M2SR, is a live-attenuated, replication-deficient influenza vaccine delivered intranasally to stimulate a comprehensive immune response, including mucosal, cellular, and antibody-mediated immunity. Unlike traditional flu shots, FluGen's technology aims to protect against mismatched or drifted strains, addressing a major limitation of current seasonal vaccines. Headquartered in Madison, Wisconsin, the company leverages its proprietary REDeeM platform to create vaccines that mimic a natural infection without causing illness.